Metabolic Health
Page 1 • 3 itemsUnlock global metabolic health market insights. NovaPharmaNews delivers critical pharma intelligence for investors, BD, and analysts.
FDA Accelerates Mental Health Treatment Access Following Presidential Executive Order on Serious Mental Illness
FDA implements new measures to expedite access to treatments for serious mental illness, including treatment-resistant conditions, following April 18 Executive Order.
NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application
NRx Pharmaceuticals reports encouraging FDA feedback on its preservative-free ketamine program, with potential approval within current review cycle for depression treatment.
NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application
NRx Pharmaceuticals reports positive FDA review of preservative-free ketamine program with only minor administrative changes requested for approval.